This map shows the geographic impact of SP Stenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SP Stenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SP Stenning more than expected).
This network shows the impact of papers produced by SP Stenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SP Stenning. The network helps show where SP Stenning may publish in the future.
Co-authorship network of co-authors of SP Stenning
This figure shows the co-authorship network connecting the top 25 collaborators of SP Stenning.
A scholar is included among the top collaborators of SP Stenning based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with SP Stenning. SP Stenning is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Allum, W H, et al.. (2008). Long term results of the MRC OEO2 randomized trial of surgery with or without preoperative chemotherapy in resectable esophageal cancer. UCL Discovery (University College London).11 indexed citations
3.
Brada, M., et al.. (2008). A RANDOMISED TRIAL OF PROCARBAZINE, CCNU AND VINCRISTINE (PCV) VS TEMOZOLOMIDE (5-DAY OR 21-DAY SCHEDULE) FOR RECURRENT HIGH GRADE GLIOMA (MRC BR12, ISRCTN83176944). UCL Discovery (University College London).7 indexed citations
4.
Cunningham, David, et al.. (2005). Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). UCL Discovery (University College London).12 indexed citations
5.
Hancock, Bruno C., John Radford, M.H. Cullen, et al.. (2004). Randomised controlled trial of ABVD vs. two multi-drug regimens (MDRs) for advanced Hodgkin's lymphoma (HL): Initial results of UKLG LY09 (ISRCTN97144519).. British Journal of Cancer. 91.1 indexed citations
6.
Oliver, R.T.D., M Mason, Hans von der Maase, et al.. (2004). A randomised trial of carboplatin versus radiotherapy for stage I seminoma of the testis, following orchidectomy: MRC TE19/EORTC 30982. UCL Discovery (University College London).1 indexed citations
Radford, John, M.H. Cullen, Matthew R. Sydes, et al.. (2003). Randomised comparison of ABVD with two multi-drug regimens (MDRs) in the treatment of advanced Hodgkin lymphoma (HL): Initial results of the UKLG LY09 study (ISRCTN 97144519).. Blood. 102(11).2 indexed citations
9.
Brada, M., et al.. (2001). Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial. Journal of Clinical Oncology.16 indexed citations
10.
Seymour, Michel, et al.. (1999). Molecular markers and the prediction of prognosis and response to therapy in colon cancer. UCL Discovery (University College London).1 indexed citations
11.
Stenning, SP, et al.. (1998). Residual masses post-chemotherapy for germ cell tumour: content, clinical features and prognosis. UCL Discovery (University College London).1 indexed citations
12.
Fosså, S.D., Stuart Kaye, S. J. Harland, et al.. (1998). Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study.. UCL Discovery (University College London).12 indexed citations
13.
Mead, G.M., NM Bleehen, A. Gregor, et al.. (1998). Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06.. UCL Discovery (University College London).1 indexed citations
14.
Stenning, SP, et al.. (1997). Value of CA15.3 in marking relapse in breast cancer. UCL Discovery (University College London).1 indexed citations
Fosså, S.D., et al.. (1996). Optimal field size in adjuvant radiotherapy (XRT) of stage I seminoma - a randomised trial. UCL Discovery (University College London).8 indexed citations
Stenning, SP, et al.. (1992). Short course adjuvant chemotherapy in high risk stage I non-seminomatous germ cell tumours of the testis - preliminary report of an MRC study. UCL Discovery (University College London).4 indexed citations
Stenning, SP, et al.. (1990). Prognostic factors for survival in advanced non-seminomatous germ cell tumours: A study by the Medical Research Council Testicular Tumours Working Party. UCL Discovery (University College London).17 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.